UBS O'Connor’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Sell |
31,861
-55,950
| -64% | -$2.03M | 0.06% | 179 |
|
|
2025
Q1 | $3.18M | Buy |
87,811
+65,527
| +294% | +$2.37M | 0.1% | 81 |
|
|
2024
Q4 | $937K | Buy |
22,284
+1,015
| +5% | +$42.7K | 0.02% | 228 |
|
|
2024
Q3 | $1.18M | Sell |
21,269
-13,859
| -39% | -$770K | 0.03% | 254 |
|
|
2024
Q2 | $1.44M | Sell |
35,128
-7,478
| -18% | -$307K | 0.04% | 239 |
|
|
2024
Q1 | $1.99M | Sell |
42,606
-14,350
| -25% | -$670K | 0.06% | 171 |
|
|
2023
Q4 | $2.72M | Sell |
56,956
-19,959
| -26% | -$954K | 0.09% | 132 |
|
|
2023
Q3 | $2.74M | Buy |
76,915
+9,567
| +14% | +$341K | 0.05% | 187 |
|
|
2023
Q2 | $3.11M | Buy |
67,348
+8,072
| +14% | +$372K | 0.07% | 186 |
|
|
2023
Q1 | $2.38M | Buy |
+59,276
| New | +$2.38M | 0.06% | 279 |
|
|
2015
Q2 | – | Sell |
-20,000
| Closed | -$1.24M | – | 825 |
|
|
2015
Q1 | $1.24M | Sell |
20,000
-5,000
| -20% | -$311K | 0.03% | 364 |
|
|
2014
Q4 | $1.1M | Buy |
+25,000
| New | +$1.1M | 0.02% | 346 |
|